Position in TXG
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,641,452
+$2,914,278 QoQ
Shares Held
225,390
-16.5% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $46,938,720 across 23 Medical Devices names. TXG ranks #1 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
This page
|
225,390 | $8,641,452 | |
| 2 | ABT |
Abbott Laboratories
|
61,262 | $5,558,913 | |
| 3 | SYK |
Stryker Corp
|
11,737 | $3,695,277 | |
| 4 | EW |
Edwards Lifesciences Corp
|
36,527 | $3,304,232 | |
| 5 | MDT |
Medtronic plc
|
31,021 | $2,426,772 | |
| 6 | PHG |
Koninklijke Philips NV
|
70,503 | $1,916,976 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
21,558 | $1,855,928 | |
| 8 | QDEL |
QuidelOrtho Corp
|
99,157 | $1,737,230 |
All Filings in TXG
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,641,452 | 225,390 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,727,174 | 269,768 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,594,495 | 220,386 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,626,100 | 224,645 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,631,899 | 140,924 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $314,620 | 36,039 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $147,391 | 10,264 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $227,741 | 10,086 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||